Cited by 141SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesGenetic Associations and Epidemiology

The DOI matches its Crossref record; 56 of the 66 references it cites were found in a registry or an index.

SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype

Open access

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). The relentless spread and pathogenicity of the virus have become a global public health emergency. One of the striking features of this pandemic is the pronounced impact on specific regions and ethnic groups. In particular, compared with East Asia, where the virus first emerged, SARS-CoV-2 has caused high rates of morbidity and mortality in Europe. This has not been experienced in past global viral infections, such as influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) and is unique to SARS-CoV-2. For this reason, we investigated the involvement of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes, because ACE2 is a receptor for SARS-CoV-2. We found that the ACE1 II genotype frequency in a population was significantly negatively correlated with the number of SARS-CoV-2 cases. Similarly, the ACE1 II genotype was negatively correlated with the number of deaths due to SARS-CoV-2 infection. These data suggest that the ACE1 II genotype may influence the prevalence and clinical outcome of COVID-19 and serve as a predictive marker for COVID-19 risk and severity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gene.2020.144944

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 4

  1. Borzyszkowska, 2012, Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels, J. Appl. Genet., 53, 175, 10.1007/s13353-012-0083-3 · DOI
  2. Gard, P.R. 2010. Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review. Int. J. Mol. Epidemiol.Genet., 1, 145-157 https://www.ijmeg.org/ijmeg102003.
  3. Gu, 1994, Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population, J. Hum. Hypertens., 8, 683
  4. Nikzamir, A., Nakhjavani, M., Golmohamadi, T., Dibai, L. 2008. Association of angiotensin-converting enzyme gene insetion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes Mellitus. Arch. Iranian Med., 11, 3-9 http://www.ams.ac.ir/AIM/NEWPUB/08/11/1/004.pdf. · DOI

Cited by

Sorted by citations

See all 141

Metadata

Authors
Yamamoto, N., Ariumi, Y., Nishida, N., Yamamoto, R., Bauer, G., Gojobori, T., Shimotohno, K., & Mizokami, M.
Affiliations
  • National Center for Global Health and Medicine (JP)
  • Joint Research Center for Human Retrovirus Infection, Kumamoto University (JP)
  • Keio University (JP)
  • University of Freiburg (DE)
  • King Abdullah University of Science and Technology (SA)
Corresponding author
  • Yamamoto, Naoki
  • Shimotohno, Kunitada
  • Mizokami, Masashi
Venue
Gene
Publisher
Elsevier BV
Published
2020-10
Volume
758
Pages
144944
ISSN
0378-1119 (ISSN-L)
OpenAlex
W3038462367
Cited by
141
References
66
Citations by year
2026: 2 · 2025: 3 · 2024: 15 · 2023: 20 · 2022: 36 · 2021: 54 · 2020: 11
FWCI
3.97
Type
journal article
Language
en
Open access
Locations
  • Gene (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) (submittedVersion, cc-by-nc-nd)
Funders
Japan Society for the Promotion of Science (18K08438)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
SARS-CoV-2, COVID-19 pandemic, ACE2 receptor, genetic susceptibility, COVID-19 mortality
MeSH terms
Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Asia, Europe, Gene Frequency, Genotype, Humans, Peptidyl-Dipeptidase A, Pneumonia, Viral, Risk, Risk Factors, Severity of Illness Index, Treatment Outcome, Coronavirus Infections, Polymorphism, Single Nucleotide, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review